Create free account
ActiveBangalore, KarnatakaSince 2018

Eurofins Advinus Biopharma Services India Private Limited

Follow

Set up in 2018 in Bangalore. It has pledged its assets against loans of up to ₹22.38 lakh from 1 lender.

CINU74999KA2018FTC118353
Get its revenue and profit

From its annual accounts, which Entiva gets and reads for you.

Ask your favourite AI

Get a plain-English summary of this company.

7 years at a glance

Loans against its assets, and when today's people joined

20192020202120222023202420252026LOANS AGAINST ITS ASSETSTODAY'S PEOPLE, WHEN THEY JOINEDRegistered as a companyAxis Bank Limited, up to ₹22.38 lakh, 9 Jan 2025 to still open
Loan still openLoan paid offSomeone joined, and is still there
  • 2018Registered as a company on 6 Nov 2018.
  • 2025Its biggest loan against assets, ₹22.38 lakh with Axis Bank Limited, is still open.

Who runs it

This page does not list its directors yet. Open the company in Entiva to see who runs it on MCA's register today.

Who has lent to it

₹22.38 lakhin loans backed by its assets, from 1 lender

  • Axis Bank Limited₹22.38 lakh

    Open, taken out 9 Jan 2025

What its filings add

Eurofins Advinus Biopharma Services India files these with the registrar. Entiva fetches and reads them for you.

Get Eurofins Advinus Biopharma Services India's filings

Same line of business

Registered for the same kind of business, closest in size first

Keep an eye on Eurofins Advinus Biopharma Services India

  • Free

    Follow the company

    An email when it files, or its directors or loans change.

  • Free

    Follow its people

    Hear when a director joins another company.

  • Free

    Map the network

    See every company its people connect to.

  • Per order

    Read the filings

    Accounts, owners and loans, in Entiva or your AI assistant.

Create a free account

No card needed to follow.

The details on this page come from public records, including MCA's register of companies as Entiva read it on . Things may have changed since. A loan amount is the most the lender can claim against the company's assets, not what is still owed.